Erste Asset Management’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$764K Hold
35,700
0.01% 469
2026
Q1
$459K Hold
35,700
﹤0.01% 520
2025
Q4
$594K Hold
35,700
0.01% 478
2025
Q3
$481K Hold
35,700
﹤0.01% 486
2025
Q2
$421K Hold
35,700
﹤0.01% 654
2025
Q1
$274K Hold
35,700
﹤0.01% 464
2024
Q4
$225K Hold
35,700
﹤0.01% 481
2024
Q3
$179K Hold
35,700
﹤0.01% 483
2024
Q2
$124K Hold
35,700
﹤0.01% 487
2024
Q1
$103K Hold
35,700
﹤0.01% 490
2023
Q4
$190K Hold
35,700
﹤0.01% 483
2023
Q3
$198K Hold
35,700
﹤0.01% 476
2023
Q2
$243K Hold
35,700
﹤0.01% 476
2023
Q1
$301K Hold
35,700
0.01% 473
2022
Q4
$270K Hold
35,700
0.01% 467
2022
Q3
$245K Hold
35,700
0.01% 482
2022
Q2
$293K Hold
35,700
0.01% 482
2022
Q1
$495K Hold
35,700
0.01% 437
2021
Q4
$937K Hold
35,700
0.02% 361
2021
Q3
$1.16M Hold
35,700
0.02% 327
2021
Q2
$1.51M Hold
35,700
0.03% 315
2021
Q1
$1.34M Hold
35,700
0.03% 315
2020
Q4
$2.12M Sell
35,700
-6,300
-15% -$325K 0.06% 258
2020
Q3
$2.02M Hold
42,000
0.07% 245
2020
Q2
$1.93M Hold
42,000
0.08% 236
2020
Q1
$1.14M Buy
+42,000
New +$1.17M 0.07% 239

Other funds holding ADPT

Erste Asset Management's ADPT Position: Q2 2026 in Review

Erste Asset Management held its Adaptive Biotechnologies (ADPT) position steady in Q2 2026 at 35,700 shares worth $764K. The position accounts for 0.01% of the portfolio, ranked #469.

Erste Asset Management first reported a position in ADPT in Q1 2020 and has held it in 26 quarters since. The position peaked at $2.12M in Q4 2020. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Erste Asset Management held 35,700 shares of Adaptive Biotechnologies worth $764K as of Q2 2026.
  • Erste Asset Management left its Adaptive Biotechnologies share count unchanged in Q2 2026.
  • Adaptive Biotechnologies made up 0.01% of Erste Asset Management's portfolio in Q2 2026, its #469 holding.
  • Erste Asset Management first reported a position in Adaptive Biotechnologies in Q1 2020 and has held it in 26 quarters since.
  • Erste Asset Management's Adaptive Biotechnologies position peaked at $2.12M in Q4 2020.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.